Clinical Trial for Early Cancer Detection Through Blood Tests in England
November 4, 2026
A new clinical trial in England will assess the effectiveness of simple blood tests for the early detection of common forms of cancer. The tests, developed by the University of Birmingham, will analyze blood samples to identify cancers and determine their origin. The trial will involve over 20,000 patients and 200 doctors, focusing mainly on abdominal cancers. Supported by technologies such as Artificial Intelligence, it aims to improve early diagnosis. Its success could transform cancer diagnosis methods in England.